Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Radiotherapy and Oncology

Volumn 100, Issue 3, 2011, Pages 463-467

  Morton, Gerard ^a   Loblaw, Andrew ^a   Cheung, Patrick ^a   Szumacher, Ewa ^a   Chahal, Manraj ^a   Danjoux, Cyril ^a   Chung, Hans T ^a   Deabreu, Andrea ^a   Mamedov, Alexandre ^a   Zhang, Liying ^a   Sankreacha, Raxa ^a   Vigneault, Eric ^b   Springer, Colvin ^c  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Centre Regional De Cancerologie De Windsor   (Canada)

Author keywords

Fractionation; HDR brachytherapy; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HEMORRHAGIC CYSTITIS; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SYNDROME CREST; URINE RETENTION;

AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDPOINT DETERMINATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 80054058873     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.08.022     Document Type: Article

References (23)

1. A.A. Martinez, J. Demanes, C. Vargas, L. Schour, M. Ghilezan, and G.S. Gustafson High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer Am J Clin Oncol 33 2010 481 488
2. G.C. Morton The emerging role of high-dose-rate brachytherapy for prostate cancer Clin Oncol (R Coll Radiol) 17 2005 219 227 (Pubitemid 40716444)
3. B.R. Pieters, D.Z. de Back, C.C. Koning, and A.H. Zwinderman Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review Radiother Oncol 93 2009 168 173
4. I.C. Hsu, K. Bae, and K. Shinohara Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321 Int J Radiat Oncol Biol Phys 78 2010 751 758
5. G.C. Morton, D.A. Loblaw, and R. Sankreacha Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life Int J Radiat Oncol Biol Phys 77 2010 811 817
6. H.A. Clarke, J. Tarshis, J. Lam-McCulloch, and J. Kay Saddle block analgesia for high-dose-rate brachytherapy: a prospective study Brachytherapy 8 2009 335 338
7. E. Lessard, and J. Pouliot Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function Med Phys 28 2001 773 779 (Pubitemid 32467255)
8. J.T. Wei, R.L. Dunn, M.S. Litwin, H.M. Sandler, and M.G. Sanda Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
9. M. Roach, G. Hanks, and H.J. Thames Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
10. G.C. Morton, D.A. Loblaw, and H. Chung Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1299 1305
11. A.A. Martinez, J. Gonzalez, and H. Ye Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
12. P.J. Hoskin, K. Motohashi, P. Bownes, L. Bryant, and P. Ostler High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial Radiother Oncol 84 2007 114 120 (Pubitemid 47284526)
13. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
14. L. Astrom, D. Pedersen, C. Mercke, S. Holmang, and K.A. Johansson Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161 (Pubitemid 40331872)
15. F. Bachand, A.G. Martin, L. Beaulieu, F. Harel, and E. Vigneault An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome Int J Radiat Oncol Biol Phys 73 2009 679 684
16. G.M. Duchesne, S.G. Williams, R. Das, and K.H. Tai Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results Radiother Oncol 84 2007 128 134 (Pubitemid 47284528)
17. L. Sullivan, S.G. Williams, K.H. Tai, F. Foroudi, L. Cleeve, and G.M. Duchesne Urethral stricture following high dose rate brachytherapy for prostate cancer Radiother Oncol 91 2009 232 236
18. P.J. Hoskin, P.J. Bownes, P. Ostler, K. Walker, and L. Bryant High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions Radiother Oncol 68 2003 285 288 (Pubitemid 38373429)
19. W. Foster, J.A. Cunha, I.C. Hsu, V. Weinberg, D. Krishnamurthy, and J. Pouliot Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy Int J Radiat Oncol Biol Phys 80 2011 85 90
20. I.K. Kolkman-Deurloo, M.A. Roos, and S. Aluwini HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation Radiother Oncol 98 2011 192 197
21. R. Holly, G.C. Morton, and R. Sankreacha Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy Brachytherapy 10 2011 299 305
22. J. Hermesse, S. Biver, and N. Jansen A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy Strahlenther Onkol 185 2009 736 742
23. G. Kovacs, R. Potter, and T. Loch GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer Radiother Oncol 74 2005 137 148 (Pubitemid 40331870)